C4D Deposition and Positive Posttransplant Crossmatch Are Not Necessarily Markers of Antibody-Mediated Rejection in Renal Allograft Recipients

作者: M. Banasik , M. Boratyńska , B. Nowakowska , A. Haloń , K. Kościelska-Kasprzak

DOI: 10.1016/J.TRANSPROCEED.2007.08.064

关键词:

摘要: Abstract The aim of the study was to search for serologic, immunopathologic, and morphologic evidence antibody-mediated rejection (AMR) among patients with acute renal allograft dysfunction. included 19 episodes (ARE) within first year after transplantation. All had negative crossmatch tests before Patients underwent biopsy histologic C4d examinations. were monitored donor-specific HLA alloantibodies during posttransplant year. Complement-dependent cytotoxic crossmatches performed donor lymphocytes. In eight patients, test results changed positive ARE. all biopsies except one cortical infarction, we observed staining (group 1). four showed changes AMR, their grafts lost. patient, cellular vascular (Banff II) present; in two, Banff I; one, borderline lesions. These compared 11 ARE but 2). findings these interstitial I II). With no features suggestive AMR. During transplantation, creatinine levels group 1 significantly higher than 2 patients. One-year graft survival 50% 91% 2. Conclusions a not associated AMR half Nevertheless, deposition correlated injury transplant

参考文章(20)
Paul I. Terasaki, Miyuki Ozawa, Predicting kidney graft failure by HLA antibodies: a prospective trial. American Journal of Transplantation. ,vol. 4, pp. 438- 443 ,(2004) , 10.1111/J.1600-6143.2004.00360.X
E E Schneeberger, S L Saidman, A B Cosimi, N Tolkoff-Rubin, R B Colvin, M A Pascual, W W Williams, A B Collins, Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. Journal of The American Society of Nephrology. ,vol. 10, pp. 2208- 2214 ,(1999) , 10.1681/ASN.V10102208
Robert A. Montgomery, Mark A. Hardy, Stanley C. Jordan, Lorraine C. Racusen, Lloyd E. Ratner, Dolly B. Tyan, Andrea A. Zachary, Consensus opinion from the antibody working group on the diagnosis, reporting, and risk assessment for antibody-mediated rejection and desensitization protocols. Transplantation. ,vol. 78, pp. 181- 185 ,(2004) , 10.1097/01.TP.0000129256.84027.D6
Judith E. Worthington, Anna McEwen, Lorna J. McWilliam, Michael L. Picton, Susan Martin, Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome. Transplantation. ,vol. 83, pp. 398- 403 ,(2007) , 10.1097/01.TP.0000251430.11723.B6
PHILIP F. HALLORAN, ARTURO WADGYMAR, SUSAN RITCHIE, JUDY FALK, KIM SOLEZ, NANGALI S. SRINIVASA, The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation. ,vol. 49, pp. 85- 91 ,(1990) , 10.1097/00007890-199001000-00019
N El-Awar, P Terasaki, V Lazda, A Nikaein, C Manning, A.N Arnold, Almost all patients who are waiting for a regraft of a kidney transplant have anti-HLA antibodies. Latin American Transplantation Congress. ,vol. 34, pp. 2531- 2532 ,(2002) , 10.1016/S0041-1345(02)03520-0
M Crespo, M Lozano, M Sole, J Mila, N Esforzado, J Martorell, F Oppenheimer, Diagnosis and treatment of acute humoral rejection after kidney transplantation: preliminary experience. Congress of the Catalan Transplantation Society. ,vol. 35, pp. 1677- 1678 ,(2003) , 10.1016/S0041-1345(03)00620-1
Shamila Mauiyyedi, Robert B. Colvin, Humoral rejection in kidney transplantation: new concepts in diagnosis and treatment. Current Opinion in Nephrology and Hypertension. ,vol. 11, pp. 609- 618 ,(2002) , 10.1097/00041552-200211000-00007
Georg B�hmig, Heinz Regele, Diagnosis and treatment of antibody‐mediated kidney allograft rejection Transplant International. ,vol. 16, pp. 773- 787 ,(2003) , 10.1007/S00147-003-0658-3
H.E. Feucht, Significance of donor-specific antibodies in acute rejection. Catalan Transplantation Society. Congress. ,vol. 37, pp. 3693- 3694 ,(2005) , 10.1016/J.TRANSPROCEED.2005.09.114